Read More Pharma Industry News BridgeBio raises $1bn in preferred equity to fund rare disease product launches BridgeBio’s $1 billion preferred equity raise strengthens BBIO’s balance sheet as Attruby grows and three rare disease launches approach. bySoujanya RaviJuly 1, 2026